Medicines in Development

Each patient battling a disease or managing a chronic condition lives in the hope that tomorrow will bring a new medicine that delivers better health. America’s biopharmaceutical research companies share the same goal, constantly developing new medicines that can prevent diseases, improve patients’ health, and save lives. 

Since 2000, more than 500 new medicines have been approved by the FDA, helping patients live longer, healthier lives. Medications are transforming many cancers into treatable conditions, reducing the impact of cardiovascular disease, offering new options for patients with hard-to-treat diseases like Alzheimer’s and Parkinson’s, and fighting even the rarest conditions. Explore the medicines in development for a wide range of diseases below. 

Report

Medicines in Development for Alzheimer's Disease 2016

America’s biopharmaceutical research companies are investigating or developing 93 medicines to help patients living with Alzheimer’s.

Report

Medicines in Development for Arthritis 2014 Report

America’s biopharmaceutical research companies are developing 92 innovative new medicines to help the millions of Americans affected by arthritis.

Report

Medicines in Development for Asthma

America’s biopharmaceutical research companies are working on 74 medicines to treat asthma.

Report

Medicines in Development for Autoimmune Diseases 2016 Report

To date, more than 80 autoimmune diseases have been identified. Learn about treatments currently in development.

Report

Medicines in Development for Biologics 2013 Report

Biologics are developed through biological processes using living cells or organisms.

Report

Medicines in Development for Cancer 2015 Report

In recent decades, tremendous – almost previously unthinkable – progress has been made in the fight against cancer.

Report

Medicines in Development for Children Report

America’s biopharmaceutical companies are researching 316 medicines to help meet the unique health care needs of children and adolescents.

Report

Medicines in Development for COPD

View the full 2012 report on COPD medicines in development.

Report

Medicines in Development for Diabetes 2016 Report

America’s biopharmaceutical research companies are currently developing more than 170 innovative new medicines to help the more than 30 million Americans affected by diabetes

Report

Medicines in Development for Heart Disease 2015 Report

View the full 2015 report on cardiovascular medicines in development.

Report

Medicines in Development for HIV/AIDS 2014 Report

44 Medicines and Vaccines Being Developed For Those Living With HIV/AIDS

Report

Medicines in Development for Infectious Diseases 2013 Report

Throughout history, infectious diseases have taken a devastating toll on the lives and well-being of people around the world.

Report

Medicines in Development for Leukemia & Lymphoma 2015 Report

Each year, more than 162,000 Americans are diagnosed with a blood cancer—accounting for more than 9 percent of all new cancer diagnoses.

Report

Medicines in Development for Mental Illnesses 2016 Report

Biopharmaceutical research companies are developing more than 130 medicines for mental illnesses.

Report

Medicines in Development for Neurological Disorders 2015

Biopharmaceutical researchers are developing more than 400 medicines for a wide range of neurological disorders.

Report

New Medicine Approvals 2015 Report

View the 2015 report on new medicine approvals.

Report

Medicines in Development for Older Americans 2013 Report

America’s biopharmaceutical research companies currently are developing 435 innovative new medicines.

Report

Medicines in Development for Osteoporosis 2016 Report

Advances in diagnosis and biopharmaceutical research bring hope to osteoporosis patients.

Report

Medicines in Development for Parkinson's Disease 2014

America’s biopharmaceutical research companies are currently developing 37 medicines to help Americans living with Parkinson’s Disease.

Report

Medicines in Development for Rare Diseases 2016 Report

30 million Americans, or 10 percent of the population, have one of the 7,000 known rare diseases, of which 80 percent are genetic in origin.

Report

Medicines in Development for Skin Diseases

Biopharmaceutical Research Companies Are Developing Nearly 300 Medicines to Treat Diseases of the Skin

Report

Medicines in Development for Vaccines 2016 Report

Vaccines have played a critical role in reducing the threat, and in many cases eliminating any reported cases, of some of the world’s most devastating infectious diseases.

Report

Medicines in Development for Women

America's pharmaceutical research and biotech companies are developing 851 medicines for diseases that affect American women.